- Home
- MDGL vs GNRC Comparison
MDGL vs GNRC Comparison
Compare MDGL & GNRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- GNRC
- Stock Information
- Founded
- MDGL 2011
- GNRC 1959
- Country
- MDGL United States
- GNRC United States
- Employees
- MDGL N/A
- GNRC N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- GNRC Metal Fabrications
- Sector
- MDGL Health Care
- GNRC Consumer Discretionary
- Exchange
- MDGL Nasdaq
- GNRC Nasdaq
- Market Cap
- MDGL 6.1B
- GNRC 10.8B
- IPO Year
- MDGL N/A
- GNRC 2010
- Fundamental
- Price
- MDGL $427.23
- GNRC $181.96
- Analyst Decision
- MDGL Strong Buy
- GNRC Buy
- Analyst Count
- MDGL 10
- GNRC 18
- Target Price
- MDGL $474.67
- GNRC $179.33
- AVG Volume (30 Days)
- MDGL 329.8K
- GNRC 811.7K
- Earning Date
- MDGL 10-30-2025
- GNRC 10-30-2025
- Dividend Yield
- MDGL N/A
- GNRC N/A
- EPS Growth
- MDGL N/A
- GNRC 54.62
- EPS
- MDGL N/A
- GNRC 6.03
- Revenue
- MDGL $515,547,000.00
- GNRC $4,411,654,000.00
- Revenue This Year
- MDGL $394.12
- GNRC $5.66
- Revenue Next Year
- MDGL $57.74
- GNRC $8.28
- P/E Ratio
- MDGL N/A
- GNRC $30.16
- Revenue Growth
- MDGL 3421.98
- GNRC 9.69
- 52 Week Low
- MDGL $200.63
- GNRC $99.50
- 52 Week High
- MDGL $457.16
- GNRC $203.25
- Technical
- Relative Strength Index (RSI)
- MDGL 62.43
- GNRC 47.88
- Support Level
- MDGL $415.53
- GNRC $179.55
- Resistance Level
- MDGL $440.90
- GNRC $192.72
- Average True Range (ATR)
- MDGL 14.03
- GNRC 4.68
- MACD
- MDGL -4.81
- GNRC -0.98
- Stochastic Oscillator
- MDGL 57.03
- GNRC 41.93
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.